Virtuoso robot wins FDA nod for bladder tumor removal

Virtuoso Surgical’s robotic system can remove lesions in one piece in a minimally invasive procedure designed to improve cancer diagnosis and staging.

By Susan Kelly • Nov. 10, 2026

Getinge hires president of acute care therapies

Stacy Beske joins Getinge from Philips and will take over the role on Dec. 1.

By Nick Paul Taylor • Nov. 10, 2026

Explore the Trendline➔

Top 5 stories from MedTech Dive

From the effects of layoffs at the Food and Drug Administration and President Donald Trump’s tariff policies to the top medtech trends of 2026, here is a collection of top stories from MedTech Dive.

By MedTech Dive staff

Novocure denied FDA approval for metastatic cancer treatment

The FDA had uncertainty about the degree of clinical benefit for Novocure’s treatment of brain metastases, the company said.

By Elise Reuter • Nov. 9, 2026

FDA seeks input on telesurgery, autonomous robotics

The agency is inviting public comment on a new discussion paper as it prepares to shape policy covering robotic medical devices with autonomous or remote teleoperation functions.

By Susan Kelly • Nov. 9, 2026

Edwards bumps up sales forecast on TAVR strength in Q3

Going forward, the heart valve maker expects procedure volumes to rise following positive study data and expanded Medicare reimbursement.

By Susan Kelly • Nov. 5, 2026

Boston Scientific, Blackstone agree to $455M deal to co-fund heart pump development

As part of the agreement, Blackstone may receive regulatory and commercial milestone payments, plus royalties on net sales. 

By Nick Paul Taylor • Nov. 5, 2026

MiniMed names David Segal chief medical officer

Segal is succeeding Robert Vigersky, who is transitioning to a chief medical officer emeritus role ahead of his planned retirement at the end of next year.

By Nick Paul Taylor • Nov. 5, 2026

Zimmer raises sales forecast despite slower knee business

CEO Ivan Tornos did not attribute the company’s performance in knees to a broader market slowdown, as competitor Stryker did last week.

By Elise Reuter • Nov. 4, 2026

Philips settles with DOJ over recalled CPAP machines

Philips will pay 288 million euros to settle an investigation related to its recall of millions of sleep and respiratory devices.

By Elise Reuter • Nov. 4, 2026

3 takeaways from TCT 2026

Edwards’ TAVR results in moderate aortic stenosis drew applause from meeting attendees, while Medtronic’s renal denervation and Abbott’s left atrial appendage closure devices also produced positive study findings.

By Susan Kelly • Nov. 4, 2026

AdvaMed Chair Mick Farrell shares his top priorities, challenges for the medtech industry

In a year where companies are grappling with cyberattacks, inflation and potential tariffs, Farrell, who is also CEO of Resmed, shared a bird’s eye view of the issues.

By Elise Reuter • Nov. 2, 2026

Abbott starts pivotal trial for mitral valve replacement device

The study is testing a device that Abbott executives believe can expand the mitral valve market.

By Nick Paul Taylor • Nov. 2, 2026

FDA posts alert about Medline beds linked to 2 deaths

The company notified customers this month that it will discontinue Medline brand beds and associated products and exit the market.

By Nick Paul Taylor • Oct. 30, 2026

Cooper Companies CEO steps down after activist investor pressure

Weeks after an investor called for leadership changes, Cooper has parted ways with its CEO and proposed a new-look board of directors.

By Nick Paul Taylor • Oct. 29, 2026

Abbott grows cardiac portfolio with Amplatzer approval for valve leaks

The first-of-its-kind transcatheter device treats paravalvular leak after valve replacement surgery, to spare the patient from another open-heart surgery.

By Susan Kelly • Oct. 29, 2026

RadNet expands into teleradiology with $350M Onrad deal

The acquisition, which will give RadNet a new professional services unit, is expected to help hospitals solve challenges with radiology coverage.

By Nick Paul Taylor • Oct. 28, 2026

Stryker completes ZuriMED takeover

The deal expands Stryker’s portfolio of fast-growing sports medicine and shoulder care devices.

By Nick Paul Taylor • Oct. 27, 2026

Medical device leaders share AI hot takes at The MedTech Conference

Medtech CEOs and consultants advised focusing on a core market and preparing for complex processes in a highly regulated industry.

By Elise Reuter • Oct. 27, 2026

Overheard in Boston: Medtech CEOs talk rising costs, turbulent markets, cyberattacks

At AdvaMed’s The MedTech Conference, CEOs from top medical device companies shared how they navigate difficult times, inflation and new technologies.

By Elise Reuter • Oct. 26, 2026

Reshoring prompts crucial decisions for medical device manufacturers

For medical device manufacturers, reshoring has been discussed for years. Now, many are putting it into action and hitting familiar capacity challenges along the way.

Oct. 26, 2026

Medtech leaders discuss AI, cybersecurity and M&A at AdvaMed’s The MedTech Conference

More than 4,000 people across the medtech sector met in Boston for one of the industry’s biggest events of the year. Catch up on all the conference news in MedTech Dive’s roundup.

By Elise Reuter • Updated Nov. 6, 2026

Edwards wins FDA approval for tricuspid valve repair device

Edwards’ approval should “strengthen the company’s position in the large and underpenetrated transcatheter tricuspid market,” analysts said.

By Nick Paul Taylor • Oct. 23, 2026

FDA flags more Olympus safety problems in import block and warning letter

The FDA import alert broadens the scope of a 2025 import action covering dozens of endoscopes and comes two weeks after a new warning letter identified numerous quality system violations.

By Susan Kelly • Oct. 22, 2026

Intuitive’s US da Vinci procedure growth slows again

Facing continued softness, Intuitive outlined opportunities to increase use of its robots in benign general surgeries.

By Nick Paul Taylor • Oct. 21, 2026

Expect more tuck-in M&A, portfolio pruning in medtech, execs say

As medical device makers face “finite” capital, portfolio reshaping will likely remain a focus in the sector.

By Susan Kelly • Oct. 21, 2026